Back
LYFE SCIENCES
Project: HERA
NM_000051.4:c.662+13_662+14del
p.?  ·  ATM
Starting
Initialising…
0%
Legacy Engine
Processing…
Classification rationale
1

NM_000051.4:c.662+13_662+14del is an intronic deletion in ATM intron 6 at positions +13 and +14 relative to the exon 6 donor site.

2

SpliceAI predicts no significant splice impact for this variant (max delta score 0.05), qualifying for BP4_Supporting per VCEP threshold of ≤0.1.

spliceai ↗
3

The variant is located at +13/+14, beyond the VCEP BP7 deep intronic cutoff of +7, with no predicted aberrant splicing, qualifying for BP7_Supporting.

spliceai ↗ cspec ↗
4

This variant is present in gnomAD v4.1 at an extremely low allele frequency of 0.00012% (2/1,613,430 alleles, no homozygotes), meeting the VCEP PM2_Supporting threshold of ≤0.001%. It is absent from gnomAD v2.1.

gnomad_v4 ↗
5

This variant has been reported in ClinVar as Likely benign by 3 clinical laboratories (VariationID 421805), though the VCEP does not permit use of BP6/PP5.

clinvar ↗
6

No functional studies, case-control data, segregation data, or co-occurrence observations have been identified for this variant in the published literature.

7

Per the ATM HBOP VCEP v1.5.0 framework, two benign supporting criteria (BP4, BP7) are met, resulting in a classification of Likely Benign (Richards et al. 2015 Rule 19: ≥2 Benign Supporting → Likely Benign).

cspec ↗ PMID:25741868 ↗
Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
Rationale
Select a criterion to inspect its explanation.
Evidence used
Gaps remaining
Rule
Publications
Research and evidence
gnomAD v2.1 evidence
v2.1
gnomAD v4.1 evidence
v4.1
01
Population
gnomAD v2.1Absent from gnomAD v2.1.
gnomAD v4.1This variant is present in gnomAD v4.1 (AF= 1.2396e-06; MAF= 0.00012%, 2/1613430 alleles, homozygotes = 0) and has highest observed frequency in the African/African American population (AF= 1.33558e-05; MAF= 0.00134%, 1/74874 alleles, homozygotes = 0).
gnomAD CanadaAvailable
ClinVar evidence
02
ClinVar
This variant has been reported in ClinVar as Likely benign (3 clinical laboratories). (ClinVarID = 421805)
03
Functional
No functional summary recorded.
In silico evidence
04
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.05).
COSMIC evidence
05
COSMIC
This variant has not previously been reported in somatic cancers (COSMIC).
06
Cancer hotspots
No cancer hotspot summary recorded.